- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
Intact Vascular가 후원하는 임상 시험
총 676 건
-
Intent Solutions, Inc.완전한
-
Intech Biopharm Ltd.완전한천식 | 만성 폐쇄성 폐질환(COPD)대만
-
Manish Mehta, MDCenter for Vascular Awareness, Albany, New York종료됨
-
Chinese Pulmonary Vascular Disease Research Group모병인류 | 폐쇄성 수면 무호흡증 | 수면 무호흡증 | 폐 고혈압 | 예언자 | 예지 | 역학 | 결과중국
-
Semmelweis University Heart and Vascular Center모집하지 않고 적극적으로
-
Vascular Innovations Co. Ltd.MedPass International모집하지 않고 적극적으로
-
Chinese Pulmonary Vascular Disease Research Group완전한
-
Chinese Pulmonary Vascular Disease Research Group완전한
-
Semmelweis University Heart and Vascular Center완전한
-
Semmelweis University Heart and Vascular Center알려지지 않은
-
Medtronic VascularMedtronic Bakken Research Center완전한
-
Medtronic VascularMedtronic Bakken Research Center완전한
-
Vascular Investigation Network Spanish Society...Hospital Clínico Universitario de Valladolid완전한수술 후 합병증 | 치명적 하지 허혈스페인
-
Intech Biopharm Ltd.완전한
-
Intech Biopharm Ltd.완전한천식 | 만성 폐쇄성 폐질환(COPD)
-
Contact Asia Pacific알려지지 않은
-
Impact Therapeutics, Inc.모병
-
Impact Therapeutics, Inc.모병
-
Infant Bacterial Therapeutics모집하지 않고 적극적으로
-
Intech Biopharm Ltd.완전한
-
Impact Therapeutics, Inc.완전한
-
Intech Biopharm Ltd.완전한
-
Intech Biopharm Ltd.완전한천식 | 만성 폐쇄성 폐질환(COPD)대만
-
Intech Biopharm Ltd.완전한
-
Vascular Investigation Network Spanish Society...Hospital Clínico Universitario de Valladolid완전한
-
Wilhelminenspital ViennaAustrian Society of Vascular Surgery모병
-
Vascular Biogenics Ltd. operating as VBL Therapeutics완전한
-
Sociedad Espanola de Angiologia y Cirugia Vascular알려지지 않은대동맥 판막 협착증 | 대동맥 판막 질환 | 대동맥 협착 | 대동맥 파열 | 대동맥 해부 | 대동맥류 | 대동맥 협착증
-
Vascular Biogenics Ltd. operating as VBL Therapeutics완전한Differential Thyroid Cancer미국
-
University of PittsburghSociety for Vascular Surgery종료됨
-
Vascular Biogenics Ltd. operating as VBL Therapeutics완전한
-
Center for Vascular Awareness, Albany, New York알려지지 않은
-
Society for Vascular Surgery Patient Safety Organization모병
-
Vascular Solutions LLCBright Research Partners; Teleflex완전한
-
Vascular Biogenics Ltd. operating as VBL Therapeutics완전한